Compound ID | 648

Update compound information

PF-00708093

Class: Oxazolidinone

Spectrum of activity: Gram-negative
Details of activity: Developed to treat infections caused by susceptible and MDR Gram-positive bacteria which was demonstrated to be the case in mouse models
Description: Penzien JB. In Vitro and In Vivo Activity of PF-00708093 and PF-02341752: New Oxazolidinone Antibacterials versus Recent Bacterial Clinical Isolates. 49th-ICAAC 2009
Institute where first reported: Pfizer, USA
Year first mentioned: 2009
Highest developmental phase: Preclinical
Development status: Inactive
Chemical structure(s):
Click here for structure editor
Molecular weight: 303.31
Iso. SMILES: CC(C)N1C(=O)CC2=C1C=CC(=C2)N3C[C@@H](OC3=O)C(=O)N
InChI Key: FKMDICPKYZOJFW-GFCCVEGCSA-N
Can. SMILES: CC(C)N1C2=CC=C(C=C2CC1=O)N3C[C@H](C(=O)N)OC3=O
InChI: InChI=1S/C15H17N3O4/c1-8(2)18-11-4-3-10(5-9(11)6-13(18)19)17-7-12(14(16)20)22-15(17)21/h3-5,8,12H,6-7H2,1-2H3,(H2,16,20)/t12-/m1/s1
External links:
PubChem link: https://pubchem.ncbi.nlm.nih.gov/compound/11609163
Citation:

AntibioticDB is supported by GARDP.

If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.